Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria, tetanus and poliomyelitis (inactivated) vaccine
- Development stage
- Unknown
- Lead developer
- Bilthoven Biologicals
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
DT-IPV is a combination vaccine developed by Bilthoven Biologicals for the prevention of diphtheria, tetanus, and poliomyelitis. It contains diphtheria toxoid, tetanus toxoid, and inactivated poliovirus (IPV) types 1, 2, and 3. The vaccine works by inducing active immunity against the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*, as well as against the three types of poliovirus. It is typically used for booster vaccinations in children, adolescents, and adults who have previously received a primary series.
- Brand names
- DT-IPV
- Other names
- Diphtheria, Tetanus and Poliomyelitis Combination Vaccine
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on diphtheria, tetanus and poliomyelitis (inactivated) vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria, tetanus and poliomyelitis (inactivated) vaccine.